Výsledky vyhledávání - Ian Robins
- Zobrazuji výsledky 1 - 20 z 37
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma Autor Mark R. Gilbert, Ying Yuan, Jimin Wu, Tito R. Mendoza, Elizabeth Vera, Antonio Omuro, Frank S. Lieberman, H. Ian Robins, Elizabeth R. Gerstner, Jing Wu, Patrick Y. Wen, Tom Mikkelsen, Kenneth Aldape, Terri S. Armstrong
Vydáno 2020Artigo -
7
A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Br... Autor Paul W. Sperduto, Meihua Wang, H. Ian Robins, Michael C. Schell, Maria Werner‐Wasik, Ritsuko Komaki, Luís Souhami, Mark K. Buyyounouski, Deepak Khuntia, William F. Demas, Sunjay Shah, Lucien Nedzi, Gad Perry, John H. Suh, Minesh P. Mehta
Vydáno 2013Artigo -
8
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs Autor Susan M. Chang, John G. Kuhn, Patrick Y. Wen, Harry S. Greenberg, David Schiff, Charles A. Conrad, Karen Fink, H. Ian Robins, Timothy F. Cloughesy, Lisa De Angelis, Jeffrey R. Razier, Kenneth R. Hess, Janet Dancey, Michael D. Prados
Vydáno 2004Artigo -
9
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients Autor Arnab Chakravarti, Meihua Wang, H. Ian Robins, Tim Lautenschlaeger, Walter J. Curran, David Brachman, Christopher J. Schultz, Ali Choucair, Marisa Dolled‐Filhart, Jason Christiansen, Mark Gustavson, Annette M. Molinaro, Paul S. Mischel, Adam P. Dicker, Markus Bredel, Minesh P. Mehta
Vydáno 2012Artigo -
10
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas Autor Nicholas Butowski, Kathleen R. Lamborn, Bee L. Lee, Michael D. Prados, Timothy F. Cloughesy, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Frank S. Lieberman, Minesh P. Mehta, H. Ian Robins, Larry Junck, Andres Μ. Salazar, Susan M. Chang
Vydáno 2008Artigo -
11
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study Autor H. Ian Robins, Peixin Zhang, Mark R. Gilbert, Arnab Chakravarti, John de Groot, Sean Grimm, Fen Wang, Frank S. Lieberman, Andra Krauze, Andy Trotti, Nimish Mohile, Andrew Y. Kee, Howard Colman, Robert Cavaliere, Santosh Kesari, Steven J. Chmura, Minesh P. Mehta
Vydáno 2015Artigo -
12
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme Autor Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Harry S. Greenberg, David Schiff, Charles A. Conrad, Karen Fink, H. Ian Robins, Lisa De Angelis, Jeffrey J. Raizer, Kenneth R. Hess, Ken Aldape, Kathleen R. Lamborn, John G. Kuhn, Janet Dancey, Michael D. Prados
Vydáno 2005Artigo -
13
Pharmacokinetic and Tumor Distribution Characteristics of Temsirolimus in Patients with Recurrent Malignant Glioma Autor John G. Kuhn, Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Harry S. Greenberg, David Schiff, Charles A. Conrad, Karen Fink, H. Ian Robins, Minesh P. Mehta, Lisa M. DeAngelis, Jeffrey J. Raizer, Kenneth R. Hess, Kathleen R. Lamborn, Janet Dancey, Michael D. Prados
Vydáno 2007Artigo -
14
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients Autor Elizabeth Vera‐Bolanos, Kenneth Aldape, Ying Yuan, Jimin Wu, Khalida Wani, Mary Jo Necesito-Reyes, Howard Colman, Girish Dhall, Frank S. Lieberman, Philippe Métellus, Tom Mikkelsen, Antonio Omuro, Sonia Partap, Michael D. Prados, H. Ian Robins, Riccardo Soffietti, Jing Wu, Mark R. Gilbert, Terri S. Armstrong
Vydáno 2014Artigo -
15
Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study Autor Michael D. Prados, W. K. Alfred Yung, Kurt A. Jaeckle, H. Ian Robins, Minesh P. Mehta, Howard A. Fine, Patrick Y. Wen, Timothy F. Cloughesy, Susan M. Chang, M. Kelly Nicholas, David Schiff, Harry S. Greenberg, Larry Junck, Karen Fink, Kenneth R. Hess, John G. Kuhn
Vydáno 2004Artigo -
16
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1 Autor Michael D. Prados, Kathleen R. Lamborn, W. K. Alfred Yung, Kurt A. Jaeckle, H. Ian Robins, Minesh P. Mehta, Howard A. Fine, Patrick Y. Wen, Timothy F. Cloughesy, Susan M. Chang, M. Kelly Nicholas, David Schiff, Harry S. Greenberg, Larry Junck, Karen Fink, Ken Hess, John G. Kuhn
Vydáno 2006Artigo -
17
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept Autor John de Groot, Yuji Piao, Hai T. Tran, Mark R. Gilbert, Hua-Kang Wu, Jun Liu, B. Nebiyou Bekele, Tim Cloughesy, Minesh P. Mehta, H. Ian Robins, Andrew B. Lassman, Lisa M. DeAngelis, Kevin Camphausen, Alice P. Chen, W.K. Alfred Yung, Michael D. Prados, Patrick Y. Wen, John V. Heymach
Vydáno 2011Artigo -
18
Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study Autor John de Groot, Kathleen R. Lamborn, Susan M. Chang, Mark R. Gilbert, Timothy F. Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank S. Lieberman, H. Ian Robins, Minesh P. Mehta, Andrew B. Lassman, Lisa M. DeAngelis, W.K. Alfred Yung, Alice P. Chen, Michael D. Prados, Patrick Y. Wen
Vydáno 2011Artigo -
19
NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma Autor Eudocia Q. Lee, Peixin Zhang, Patrick Y. Wen, Elizabeth R. Gerstner, David A. Reardon, Kenneth Aldape, John DeGroot, Edward Pan, Jeffrey J. Raizer, Lyndon J. Kim, Steven J. Chmura, H. Ian Robins, Jennifer Connelly, James Battiste, John L. Villano, Naveed Wagle, Ryan Merrell, Merideth M Wendland, Minesh P. Mehta
Vydáno 2020Artigo -
20
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma Autor Andrew D. Norden, Jeffrey J. Raizer, Lauren E. Abrey, Kathleen R. Lamborn, Andrew B. Lassman, Susan M. Chang, W.K. Alfred Yung, Mark R. Gilbert, Howard A. Fine, Minesh P. Mehta, Lisa M. DeAngelis, Timothy F. Cloughesy, H. Ian Robins, Kenneth Aldape, Janet Dancey, Michael D. Prados, Frank S. Lieberman, Patrick Y. Wen
Vydáno 2009Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Oncology
Cancer research
Cancer
Phases of clinical research
Chemotherapy
Surgery
Glioma
Radiation therapy
Pathology
Temozolomide
Biology
Progression-free survival
Gastroenterology
Biochemistry
Clinical endpoint
Clinical trial
Gene
Glioblastoma
Toxicity
Epidermal growth factor receptor
Bevacizumab
Overall survival
Chemistry
Confidence interval
Disease
Ependymoma
Pharmacology
Tumor progression